tirzepatide approved for FDA Grants a New Indication Obesity Management Compounded Tirzepatide for Weight Loss

Industry developments indicate growing attention toward product verification, independent laboratory testing, and manufacturing transparency as research organizations continue to evaluate sourcing standards for specialized compounds

Aetna (CVS Caremark) places Mounjaro as a preferred brand with documented A1c and metformin PA

Video: GLP-1 Dose Confusion - mg vs Units Explained A physician assistant walks through the conceptual difference between mg and syringe units for GLP-1 medications including tirzepatide

Originally approved as Ozempic for type 2 diabetes in 2017, the weekly injection makes patients feel satiated, and received FDA approval in 2021 as the anti-obesity drug Wegovy, after a study in which obese patients lost an average of 14.9 percent of their body weight in 68 weeks